MODINATUR NSE filing

Modi Naturals FY26: Revenue up 8.5% to ₹719.2 Cr, PAT surges 62.1% to ₹50.3 Cr

The RealCase readHigh impact Positive

Modi Naturals reported FY26 consolidated revenue of ₹719.2 Cr (up 8.5% YoY) and PAT of ₹50.3 Cr (up 62.1% YoY). EBITDA rose 31.2% to ₹73.5 Cr. ROCE improved to 19.9%. The company provided FY27 guidance expecting revenue of ₹925-965 Cr.

Why it matters

The significant increase in key financial metrics (revenue, EBITDA, PAT), coupled with an improved credit rating and positive future guidance, suggests a material positive impact on the company's financial health and investor perception.

The market read

The company reported strong year-on-year growth in revenue, EBITDA, and PAT, along with an improved ROCE and a credit rating upgrade, indicating a positive financial performance and outlook.

Modi Naturals Limited has announced its financial results for the fiscal year ended March 31, 2026. The company reported a consolidated revenue from operations of ₹719.2 crore, an increase of 8.5% year-on-year. EBITDA saw a significant jump of 31.2% to ₹73.5 crore, while Profit After Tax (PAT) surged by 62.1% to ₹50.3 crore.

The company's ROCE improved to 19.9% from 18.3% in the previous year, and the Debt/Equity ratio decreased to 0.94 as of March 2026 from 1.22 in March 2025. Net working capital days also improved to 62 days from 66 days.

Mr. Akshay Modi, Joint Managing Director, highlighted that FY26 was an inflection point, with the company achieving its guidance across revenue, EBITDA, and PAT. He noted the progress in the Consumer Division with improved brand recall and distribution, stability in the Bulk Division, and the Ethanol business emerging as a key growth engine with capacity expansion. The company also strategically shut down one solvent extraction plant at Pilibhit.

Furthermore, Modi Naturals saw an upgrade in its credit ratings, with long-term facilities revised to IVR BBB/Stable and short-term facilities upgraded to IVR A3+. The company has provided guidance for FY27, projecting revenue between ₹925-965 crore, EBITDA of ₹100-105 crore, and PAT of ₹66-70 crore.

Filing to action

What to do with a filing like this

Modi Naturals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Modi Naturals Limited. Read the original for the full detail.

View original filing